INPOMIA Trademark

Trademark Overview


On Tuesday, November 1, 2011, a trademark application was filed for INPOMIA with the United States Patent and Trademark Office. The USPTO has given the INPOMIA trademark a serial number of 85461192. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 21, 2015. This trademark is owned by Eli Lilly and Company. The INPOMIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants
inpomia

General Information


Serial Number85461192
Word MarkINPOMIA
Filing DateTuesday, November 1, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 21, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 25, 2012

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 7, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, December 21, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 21, 2015ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 14, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 13, 2015EXTENSION 5 GRANTED
Friday, April 24, 2015EXTENSION 5 FILED
Friday, April 24, 2015TEAS EXTENSION RECEIVED
Thursday, November 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 12, 2014EXTENSION 4 GRANTED
Friday, October 31, 2014EXTENSION 4 FILED
Friday, October 31, 2014TEAS EXTENSION RECEIVED
Tuesday, April 15, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 14, 2014EXTENSION 3 GRANTED
Wednesday, April 2, 2014EXTENSION 3 FILED
Wednesday, April 2, 2014TEAS EXTENSION RECEIVED
Thursday, October 31, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 30, 2013EXTENSION 2 GRANTED
Monday, October 21, 2013EXTENSION 2 FILED
Monday, October 21, 2013TEAS EXTENSION RECEIVED
Friday, May 17, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 16, 2013EXTENSION 1 GRANTED
Monday, April 22, 2013EXTENSION 1 FILED
Friday, May 10, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 22, 2013TEAS EXTENSION RECEIVED
Tuesday, November 20, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 25, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 25, 2012PUBLISHED FOR OPPOSITION
Wednesday, September 5, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 21, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 16, 2012ASSIGNED TO LIE
Wednesday, August 8, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 7, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 7, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 7, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 10, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 10, 2012NON-FINAL ACTION E-MAILED
Friday, February 10, 2012NON-FINAL ACTION WRITTEN
Wednesday, February 8, 2012ASSIGNED TO EXAMINER
Monday, November 7, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 4, 2011NEW APPLICATION ENTERED IN TRAM